Yongsub Kim
Overview
Explore the profile of Yongsub Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Im S, Seo J, You J, Bang H, Kim Y, Kweon J, et al.
Mol Metab
. 2025 Feb;
94:102113.
PMID: 39961401
Objectives: Increased expression of glutaminase (GLS) has been found to correlate with more aggressive disease and poorer prognosis in patients with several types of cancer, including breast, lung, and pancreatic...
2.
Kim H, Hong J, Kim Y, Choi J
Toxicol Res
. 2024 Sep;
40(4):561-569.
PMID: 39345749
Breast cancer has the highest incidence of all cancer types in women. Triple-negative breast cancer (TNBC) accounts for 15% of all breast cancer cases and is the most aggressive type,...
3.
Kim H, Kweon J, Kim Y
Exp Mol Med
. 2024 Mar;
56(4):861-869.
PMID: 38556550
Advances in sequencing technology have greatly increased our ability to gather genomic data, yet understanding the impact of genetic mutations, particularly variants of uncertain significance (VUSs), remains a challenge in...
4.
Oh M, Kim Y, Han J, Kim Y, Kim D, Kim K, et al.
ACS Appl Mater Interfaces
. 2024 Feb;
16(10):13139-13149.
PMID: 38415664
Lifetime-reconfigurable soft robots have emerged as a new class of robots, emphasizing the unmet needs of futuristic sustainability and security. Trigger-transient materials that can both actuate and degrade on-demand are...
5.
Han A, Shin H, Kwon J, Lee S, Lee S, Kim E, et al.
BMB Rep
. 2023 Dec;
57(1):60-65.
PMID: 38053293
The CRISPR-Cas9 system has significantly advanced regenerative medicine research by enabling genome editing in stem cells. Due to their desirable properties, mesenchymal stem cells (MSCs) have recently emerged as highly...
6.
Jang G, Kweon J, Kim Y
Commun Biol
. 2023 Jun;
6(1):681.
PMID: 37391511
KRAS is the most commonly mutated RAS family gene and is a primary cause of the occurrence of several types of cancer. However, KRAS mutations have several unique and diverse...
7.
Jang G, Shin H, Do H, Kweon J, Hwang S, Kim S, et al.
Mol Ther Nucleic Acids
. 2023 Mar;
31:586-595.
PMID: 36910714
Lesch-Nyhan syndrome (LNS) is inherited as an X-linked recessive genetic disorder caused by mutations in hypoxanthine-guanine phosphoribosyl transferase 1 (). Patients with LNS show various clinical phenotypes, including hyperuricemia, gout,...
8.
Kim E, Kim J, Kim Y, Choi B, Sohn D, Park S, et al.
Cell Biosci
. 2023 Mar;
13(1):48.
PMID: 36882866
Background: Parkin dysfunction associated with the progression of parkinsonism contributes to a progressive systemic skeletal disease characterized by low bone mineral density. However, the role of parkin in bone remodeling...
9.
Kweon J, Jang A, Kwon E, Kim U, Shin H, See J, et al.
Exp Mol Med
. 2023 Jan;
55(2):377-384.
PMID: 36720917
Various CRISPR‒Cas9 orthologs are used in genome engineering. One of the smallest Cas9 orthologs is cjCas9 derived from Campylobacter jejuni, which is a highly specific genome editing tool. Here, we...
10.
Kim J, Lee J, Jeon S, Kim Y, Jeon S, Wu H
Cancer Res Treat
. 2023 Jan;
55(3):737-745.
PMID: 36596724
Purpose: Exogenous epidermal growth factor (EGF) causes apoptosis in EGF receptor (EGFR)-overexpressing cell lines. The apoptosis-inducing factors could be a therapeutic target. We aimed to determine the mechanism of EGF-induced...